Diabetic Macular Oedema and the Importance of Vascular Endothelial Growth Factor Therapies in Its Treatment

European Ophthalmic Review
doi 10.17925/eor.2014.08.01.i
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Vascular Endothelial Growth Factor Inhibitors in the Treatment of Neovascular Age-Related Macular Degeneration

Vestnik Oftalmologii
MedicineOphthalmology
2017English

Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2016English

Effect of Dexamethasone Intravitreal Implant on Blood Glucose, Hypothalamic-Pituitary-Adrenal Axis Function and Vascular Endothelial Growth Factor Serum Levels in Patients With Diabetic Macular Oedema

Acta Ophthalmologica
MedicineOphthalmology
2017English

Aflibercept – Setting Its Sights on Diabetic Macular Oedema

European Ophthalmic Review
2014English

Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy

2010English

Upregulated Expression of Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1996English

Vitreomacular Traction Affects Anti-Vascular Endothelial Growth Factor Treatment Outcomes for Exudative Age-Related Macular Degeneration

Retina
MedicineOphthalmology
2015English

Early and Long-Term Responses to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data

American Journal of Ophthalmology
Ophthalmology
2016English

Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) in Ischemic Skeletal Muscle and Its Regeneration

American Journal of Pathology
Forensic MedicinePathology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy